{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:26:19Z","timestamp":1788452779303,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shaanxi Provincial natural science basic research Project","award":["S2024JC-YBQN-0836"],"award-info":[{"award-number":["S2024JC-YBQN-0836"]}]},{"name":"Shaanxi Provincial natural science basic research Project","award":["S2024JC-YBQN-0836"],"award-info":[{"award-number":["S2024JC-YBQN-0836"]}]},{"name":"Shaanxi Provincial natural science basic research Project","award":["S2024JC-YBQN-0986"],"award-info":[{"award-number":["S2024JC-YBQN-0986"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-026-07875-7","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T20:04:31Z","timestamp":1778702671000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The resistance mechanisms and risk factors of carbapenem-resistant Klebsiella pneumoniae to ceftazidime-avibactam"],"prefix":"10.1186","volume":"19","author":[{"given":"Xiaqin","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Waqas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"7875_CR1","doi-asserted-by":"crossref","unstructured":"He J, Shi Q, Chen Z et al. Opposite evolution of pathogenicity driven by in vivo wzc and wcaJ mutations in ST11-KL64 carbapenem-resistant Klebsiella pneumoniae. Drug Resist Updat,2023,66:100891.","DOI":"10.1016\/j.drup.2022.100891"},{"key":"7875_CR2","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2147\/IDR.S292431","volume":"14","author":"E Liu","year":"2021","unstructured":"Liu E, Jia P, Li X, et al. In vitro and in vivo Effect of Antimicrobial Agent Combinations Against Carbapenem-Resistant Klebsiella pneumoniae with Different Resistance Mechanisms in China. Infect Drug Resist. 2021;14:917\u201328.","journal-title":"Infect Drug Resist"},{"key":"7875_CR3","doi-asserted-by":"crossref","unstructured":"Wang YY, Jiang M, Liu SJ et al. The synergistic effect of imipenem combined with ceftazidime-avibactam against Klebsiella pneumoniae with alternating resistance to CZA and carbapenem. J Microbiol Immunol Infect,2025.","DOI":"10.1016\/j.jmii.2025.04.005"},{"issue":"Suppl 1","key":"7875_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.37201\/req\/s01.09.2022","volume":"35","author":"HF Sanz","year":"2022","unstructured":"Sanz HF. Ceftazidime-avibactam. Rev Esp Quimioter. 2022;35(Suppl 1):40\u20132.","journal-title":"Rev Esp Quimioter"},{"key":"7875_CR5","doi-asserted-by":"crossref","unstructured":"Xiong L, Wang X, Wang Y et al. Molecular mechanisms underlying bacterial resistance to ceftazidime\/avibactam. WIREs Mech Dis 2022,14(6):e1571.","DOI":"10.1002\/wsbm.1571"},{"key":"7875_CR6","doi-asserted-by":"crossref","unstructured":"Jean SS, Chang HT, Huang CL et al. Distributions of plasmidic genes encoding extended-spectrum and AmpC beta-lactamases, and susceptibilities of global non-carbapenemase-producing meropenem-resistant Enterobacterales to ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam-avibactam, 2017\u20132022. J Infect,2025,90(2):106380.","DOI":"10.1016\/j.jinf.2024.106380"},{"key":"7875_CR7","doi-asserted-by":"crossref","unstructured":"Liu X, Chu Y, Yue H, et al. Risk factors for and clinical outcomes of ceftazidime-avibactam-resistant carbapenem-resistant Klebsiella pneumoniae nosocomial infections: a single-center retrospective study. Volume 50. Infection; 2022. pp. 1147\u201354. 5.","DOI":"10.1007\/s15010-022-01781-3"},{"key":"7875_CR8","doi-asserted-by":"crossref","unstructured":"Ding L, Shen S, Chen J et al. Klebsiella pneumoniae carbapenemase variants: the new threat to global public health. Clin Microbiol Rev 2023,36(4):e823.","DOI":"10.1128\/cmr.00008-23"},{"key":"7875_CR9","doi-asserted-by":"crossref","unstructured":"Pogue JM, Jones RN, Bradley JS et al. Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST). Antimicrob Agents Chemother,2020,64(2).","DOI":"10.1128\/AAC.01495-19"},{"issue":"1","key":"7875_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","volume":"70","author":"L Poirel","year":"2011","unstructured":"Poirel L, Walsh TR, Cuvillier V, et al. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119\u201323.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"7875_CR11","doi-asserted-by":"crossref","unstructured":"Zhu X, Guo C, Xu S et al. Clinical distribution of carbapenem genotypes and resistance to ceftazidime-avibactam in Enterobacteriaceae bacteria. Front Cell Infect Microbiol 2024,14:1345935.","DOI":"10.3389\/fcimb.2024.1345935"},{"issue":"5","key":"7875_CR12","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jinf.2022.03.010","volume":"84","author":"T Lou","year":"2022","unstructured":"Lou T, Du X, Zhang P, et al. Risk factors for infection and mortality caused by carbapenem-resistant Klebsiella pneumoniae: A large multicentre case-control and cohort study. J Infect. 2022;84(5):637\u201347.","journal-title":"J Infect"},{"issue":"1","key":"7875_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12941-025-00797-5","volume":"24","author":"SY Liu","year":"2025","unstructured":"Liu SY, Chou SH, Chuang C, et al. Clinical and Microbiological characteristics of patients with ceftazidime\/avibactam-resistant Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae strains. Ann Clin Microbiol Antimicrob. 2025;24(1):26.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"7875_CR14","doi-asserted-by":"crossref","unstructured":"Zhang J, Xu J, Shen S et al. Comparison of three colloidal gold immunoassays and GeneXpert Carba-R for the detection of Klebsiella pneumoniae bla(KPC-2) variants. J Clin Microbiol 2024,62(7):e15424.","DOI":"10.1128\/jcm.00154-24"},{"issue":"5","key":"7875_CR15","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.1016\/S2666-5247(24)00018-1","volume":"5","author":"FP Sellera","year":"2024","unstructured":"Sellera FP, Lincopan N, Fuentes-Castillo D, et al. Rapid evolution of pan-beta-lactam resistance in Enterobacterales co-producing KPC and NDM: insights from global genomic analysis after the COVID-19 pandemic. Lancet Microbe. 2024;5(5):e412\u20133.","journal-title":"Lancet Microbe"},{"key":"7875_CR16","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.2147\/IDR.S455146","volume":"17","author":"J Li","year":"2024","unstructured":"Li J, Wu W, Wu M, et al. Clinical and Molecular Characteristics of Patients with Bloodstream Infections Caused by KPC and NDM Co-Producing Carbapenem-Resistant Klebsiella pneumoniae. Infect Drug Resist. 2024;17:1685\u201397.","journal-title":"Infect Drug Resist"},{"issue":"9","key":"7875_CR17","doi-asserted-by":"publisher","first-page":"e0044722","DOI":"10.1128\/aac.00447-22","volume":"66","author":"CA Hobson","year":"2022","unstructured":"Hobson CA, Pierrat G, Tenaillon O, et al. Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview. Antimicrob Agents Chemother. 2022;66(9):e0044722.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"7875_CR18","doi-asserted-by":"publisher","first-page":"2361007","DOI":"10.1080\/22221751.2024.2361007","volume":"13","author":"Q Shi","year":"2024","unstructured":"Shi Q, Shen S, Tang C, et al. Molecular mechanisms responsible KPC-135-mediated resistance to ceftazidime-avibactam in ST11-K47 hypervirulent Klebsiella pneumoniae. Emerg Microbes Infect. 2024;13(1):2361007.","journal-title":"Emerg Microbes Infect"},{"issue":"5","key":"7875_CR19","doi-asserted-by":"publisher","first-page":"e72523","DOI":"10.1128\/spectrum.00725-23","volume":"11","author":"X Huang","year":"2023","unstructured":"Huang X, Shen S, Chang F, et al. Emergence of KPC-134, a KPC-2 variant associated with ceftazidime-avibactam resistance in a ST11 Klebsiella pneumoniae clinical strain. Microbiol Spectr. 2023;11(5):e72523.","journal-title":"Microbiol Spectr"},{"key":"7875_CR20","doi-asserted-by":"crossref","unstructured":"Wang C, Zhao J, Liu Z et al. In vivo Selection of Imipenem Resistance Among Ceftazidime-Avibactam-Resistant, Imipenem-Susceptible Klebsiella pneumoniae Isolate With KPC-33 Carbapenemase. Front Microbiol,2021,12:727946.","DOI":"10.3389\/fmicb.2021.727946"},{"key":"7875_CR21","doi-asserted-by":"crossref","unstructured":"Ding L, Shen S, Han R et al. Ceftazidime-Avibactam in Combination with Imipenem as Salvage Therapy for ST11 KPC-33-Producing Klebsiella pneumoniae. Antibiotics (Basel),2022,11(5).","DOI":"10.3390\/antibiotics11050604"},{"issue":"1","key":"7875_CR22","doi-asserted-by":"publisher","first-page":"107388","DOI":"10.1016\/j.ijantimicag.2024.107388","volume":"65","author":"W Yang","year":"2025","unstructured":"Yang W, Xu H, Zhao Y, et al. Identification of bla(KPC-90) in Klebsiella pneumoniae associated with ceftazidime-avibactam resistance and the translocation & truncation of resistant genes mediated by IS26. Int J Antimicrob Agents. 2025;65(1):107388.","journal-title":"Int J Antimicrob Agents"},{"key":"7875_CR23","doi-asserted-by":"crossref","unstructured":"Nelson K, Hemarajata P, Sun D et al. Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella pneumoniae with Increased Efflux Activity. Antimicrob Agents Chemother,2017,61(10).","DOI":"10.1128\/AAC.00989-17"},{"issue":"2","key":"7875_CR24","doi-asserted-by":"publisher","first-page":"107244","DOI":"10.1016\/j.ijantimicag.2024.107244","volume":"64","author":"SH Chou","year":"2024","unstructured":"Chou SH, Chuang C, Juan CH, et al. Mechanisms and fitness of ceftazidime\/avibactam-resistant Klebsiella pneumoniae clinical strains in Taiwan. Int J Antimicrob Agents. 2024;64(2):107244.","journal-title":"Int J Antimicrob Agents"},{"key":"7875_CR25","doi-asserted-by":"crossref","unstructured":"Tiseo G, Falcone M, Leonildi A et al. Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-, Cefiderocol-Resistant ST-512 Klebsiella pneumoniae-Producing KPC-31, a D179Y Variant of KPC-3. Open Forum Infect Dis 2021,8(6):ofab141.","DOI":"10.1093\/ofid\/ofab141"},{"issue":"3","key":"7875_CR26","doi-asserted-by":"publisher","first-page":"107411","DOI":"10.1016\/j.ijantimicag.2024.107411","volume":"65","author":"P Zhou","year":"2025","unstructured":"Zhou P, Gao H, Li M, et al. Characterization of a novel KPC-2 variant, KPC-228, conferring resistance to ceftazidime-avibactam in an ST11-KL64 hypervirulent Klebsiella pneumoniae. Int J Antimicrob Agents. 2025;65(3):107411.","journal-title":"Int J Antimicrob Agents"},{"key":"7875_CR27","doi-asserted-by":"crossref","unstructured":"Venditti C, Butera O, Meledandri M et al. Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniae. Clin Microbiol Infect 2021,27(7):1040\u20131.","DOI":"10.1016\/j.cmi.2021.03.001"},{"key":"7875_CR28","doi-asserted-by":"crossref","unstructured":"Gong Y, Feng Y, Lv X. Identification of a Novel KPC Variant, KPC-204, Conferring Resistance to Both Carbapenems and Ceftazidime-Avibactam in an ST11 Klebsiella pneumoniae Strain. Microorganisms,2024,12(6).","DOI":"10.3390\/microorganisms12061193"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-026-07875-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-026-07875-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-026-07875-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:45:13Z","timestamp":1783615513000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13104-026-07875-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7875"],"URL":"https:\/\/doi.org\/10.1186\/s13104-026-07875-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7507415\/v1","asserted-by":"object"}]},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was conducted in accordance with the Declaration of Helsinki and was approved by the Medical Ethics Committee of the First Affiliated Hospital of Xi\u2019an Jiaotong University, which waived pan-informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"287"}}